生物標誌物測試服務全球市場規模調查和預測：按產品（生物標誌物分析開發,流式細胞術等）,最終用戶（製藥/生物技術公司,研究機構,CRO）,地區分析2022-2029

2021 年全球生物標誌物檢測服務市場價值約為 7.596 億美元，並預計在 2022-2029 年預測期內以超過 6.9% 的健康增長率增長。

生物標誌物檢測服務提供了一種測量生物過程的強大方法，不僅可以作為對藥理干預做出反應的正常狀態的指標，還可以作為病理狀態的指標。 長期以來，醫生們一直使用血液和其他體液中 DNA 或蛋白質水平的生物標誌物分析來研究人類疾病。 癌症、免疫反應、遺傳疾病和心血管疾病等臨床疾病是醫生經常使用生物標記服務識別和治療的疾病。 由於對癌症檢測的生物標誌物測試需求增加以及研發活動增加等因素，生物標誌物測試服務市場正在擴大。

正在發現用於研究和開發的新生物標誌物。 例如，在 2020 年，sTNFR2 被確定為用於診斷急性成人 T 細胞白血病/淋巴瘤的新型生物標誌物。 同樣，2018 年，FDA 批准了瘧原蟲 18S rRNA/rDNA 生物標誌物用於治療瘧疾。 由於這些發現和技術改進，市場預計在預測期內將實現盈利增長。 如果該產品成功推出，它可能會為患者提供另一種選擇。 此外，臨床研究中對生物標誌物的需求不斷增加，慢性病和傳染病負擔的增加支持對生物標誌物檢測的需求，正在推動市場實現利潤豐厚的增長。 然而，生物標誌物檢測服務的高成本和高資本投資以及生物標誌物開發的長期時間表將阻礙整個 2022-2029 年預測期內的市場增長。

全球生物標誌物檢測服務市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於主要市場參與者的存在不斷增加、實驗室診斷測試的增加以及與生活方式相關的疾病的流行等因素，北美佔據了市場份額。 CDC預測，2020年北美約有3730萬糖尿病患者，其中2870萬確診，850萬未確診。 老年人和目標人群的增長、生物仿製藥開發研究合作的增加、主要參與者的地域擴張以及政府機構和非營利組織對市場空間的積極參與將在預測期內推動亞太地區的增長。這些只是其中的一小部分該地區有望實現顯著增長的因素。

這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年各細分市場的全球市場估計和預測
  • 生物標誌物檢測服務市場：按地區劃分，2019-2029 年
  • 生物標誌物檢測服務市場：按產品分類，2019-2029 年
  • 生物標誌物檢測服務市場：按最終用戶分類，2019-2029 年
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章生物標誌物檢測服務的全球市場定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第 3 章全球生物標誌物檢測服務市場動態

• 生物標誌物檢測服務市場影響分析 (2019-2029)
  • 市場驅動因素
    • 對用於癌症檢測的生物標誌物檢測的需求增加
    • 增加研發活動
  • 市場挑戰
    • 生物標誌物檢測服務成本高
    • 生物標誌物開發的資本投資高且時間長
  • 市場機會
    • 慢性病和傳染病負擔的增加支持對生物標誌物檢測的需求

第 4 章全球生物標誌物檢測服務市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 投資招聘模式
• 分析師的結論和建議
• 頂級投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球生物標誌物檢測服務市場：按產品分類

• 市場概況
• 生物標誌物檢測服務的全球市場：按產品、性能潛力分析
• 2019-2029 年全球生物標誌物檢測服務市場、按產品估算和預測
• 生物標誌物檢測服務市場，細分分析
  • 生物標誌物分析開發
  • 流式細胞術
  • 其他

第 7 章：全球生物標誌物檢測服務市場，按最終用戶分類

• 市場概況
• 生物標誌物測試服務的全球市場：最終用戶的性能潛力分析
• 2019-2029 年最終用戶的生物標誌物測試服務全球市場、估計和預測
• 生物標誌物檢測服務市場，細分分析
  • 製藥公司、生物技術公司
  • 研究機構
  • 首席風險官

第 8 章全球生物標誌物檢測服務市場：區域分析

• 生物標誌物檢測服務市場，按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年按產品估算和預測
    • 2019-2029 年最終用戶的估計和預測
  • 加拿大
• 歐洲生物標誌物檢測服務市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太生物標誌物檢測服務市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲生物標誌物檢測服務市場概況
  • 巴西
  • 墨西哥
• 世界其他地區

第 9 章衝突信息

• 頂級市場策略
• 公司簡介
  • 生物 Agilytix 實驗室
    • 主要信息
    • 概覽
    • 財務信息（取決於數據可用性）
    • 產品概述
    • 近期趨勢
  • Euro fins Scientific
  • SGS SA
  • Charles River Laboratories
  • Labcorp Drug Development
  • Thermo Fisher Scientific Inc.（PPD, Inc.）
  • ICON Plc
  • IQVIA
  • Syneos Health
  • Intertek Group Plc

第 10 章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global Biomarker Testing Services Market is valued at approximately USD 759.6 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.9% over the forecast period 2022-2029. Biomarker testing services give a powerful approach to measuring a biological process and act as an indicator in normal as well as pathological conditions in response to pharmacological intervention. To research human diseases, doctors have used biomarker analysis in blood or other body fluids at the DNA or protein level for many years. Clinical illnesses such as cancer, immunological responses, genetic disorders, and cardiovascular diseases are among the conditions that doctors frequently use biomarker services to identify and treat. The Biomarker Testing Services market is expanding because of factors such as increasing demand for biomarker testing for cancer detection and increasing R&D activities.

New biomarkers are being discovered because of research and development. For instance, sTNFR2 was identified as a novel biomarker for the diagnosis of acute adult T-cell leukemia/lymphoma in 2020. Similar to this, in 2018 the FDA approved the Plasmodium 18S rRNA/rDNA biomarker for the treatment of malaria. Due to these discoveries and technical improvements, the market is predicted to grow profitably during the forecast period. The successful launch of this product may provide patients with an alternative option. Furthermore, the growing demand for biomarkers in clinical studies and the growing burden of chronic and infectious diseases supporting demand for biomarker testing is creating lucrative growth in the market. However, the high cost of biomarker testing services and high capital investments and lengthy timelines for biomarker development stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biomarker Testing Services Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market share owing to factors such as the rising presence of key market players, increase in laboratory diagnostic testing, and prevalence of lifestyle diseases. In 2020, the CDC projects that there may be about 37.3 million diabetes in the country, including 28.7 million cases that have been diagnosed and 8.5 million that have not. A growing geriatric and target population, an increase in the number of collaborations for biosimilar development, the geographic expansion of key players, and active participation by government and nonprofit organisations in the market space are just a few of the factors driving Asia Pacific's expected significant growth during the forecast period.

Major market players included in this report are:

Bio Agilytix Labs

Eurofins Scientific

SGS SA

Charles River Laboratories

Labcorp Drug Development

Thermo Fisher Scientific Inc. (PPD, Inc.)

ICON Plc

IQVIA

Syneos Health

Intertek Group Plc

Recent Developments in the Market:

• In April2021, Amgen announced the launch of Biomarker AssistTM, a programme to make biomarker testing more accessible to patients with metastatic (stage IV) non-small cell lung cancer (NSCLC). A crucial initial step in placing patients on the appropriate course of treatment is biomarker testing at the time of diagnosis. Eligible patients may receive discounts on biomarker testing through Biomarker AssistTM.
• In February 2022, oncodna introduced the launch of the oncodeep kit. a complete workflow solution is provided by the kit, permitting laboratories with ngs capabilities to perform comprehensive biomarker testing, provide powerful data analysis, and support oncologists in the most effective and personalized treatments for their cancer patients. For the quick analysis and reporting of a patient's tumor molecular profile, the offer will come in combination with oncodna's data analysis and clinical interpretation tools.

Global Biomarker Testing Services Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Biomarker Assay Development

Flow Cytometry

Others

By End User:

Pharmaceutical and biotechnology companies

Research Institutes

CRO

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Biomarker Testing Services Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Biomarker Testing Services Market, by Product, 2019-2029 (USD Million)
  • 1.2.3. Biomarker Testing Services Market, by End User, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biomarker Testing Services Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biomarker Testing Services Market Dynamics

• 3.1. Biomarker Testing Services Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing demand for biomarker testing for cancer detection
    • 3.1.1.2. Increasing R&D activities
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Biomarker Testing Services
    • 3.1.2.2. High capital investments and lengthy timelines for biomarker development
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing burden of chronic and infectious diseases supporting demand for biomarker testing

Chapter 4. Global Biomarker Testing Services Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biomarker Testing Services Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Biomarker Testing Services Market by Product, Performance - Potential Analysis
• 6.3. Global Biomarker Testing Services Market Estimates & Forecasts by Product 2019-2029 (USD Million)
• 6.4. Biomarker Testing Services Market, Sub Segment Analysis
  • 6.4.1. Biomarker Assay Development
  • 6.4.2. Flow Cytometry
  • 6.4.3. Others

Chapter 7. Global Biomarker Testing Services Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Biomarker Testing Services Market by End User, Performance - Potential Analysis
• 7.3. Global Biomarker Testing Services Market Estimates & Forecasts by End User 2019-2029 (USD Million)
• 7.4. Biomarker Testing Services Market, Sub Segment Analysis
  • 7.4.1. Pharmaceutical and biotechnology companies
  • 7.4.2. Research Institutes
  • 7.4.3. CRO

Chapter 8. Global Biomarker Testing Services Market, Regional Analysis

• 8.1. Biomarker Testing Services Market, Regional Market Snapshot
• 8.2. North America Biomarker Testing Services Market
  • 8.2.1. U.S. Biomarker Testing Services Market
    • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Biomarker Testing Services Market
• 8.3. Europe Biomarker Testing Services Market Snapshot
  • 8.3.1. U.K. Biomarker Testing Services Market
  • 8.3.2. Germany Biomarker Testing Services Market
  • 8.3.3. France Biomarker Testing Services Market
  • 8.3.4. Spain Biomarker Testing Services Market
  • 8.3.5. Italy Biomarker Testing Services Market
  • 8.3.6. Rest of Europe Biomarker Testing Services Market
• 8.4. Asia-Pacific Biomarker Testing Services Market Snapshot
  • 8.4.1. China Biomarker Testing Services Market
  • 8.4.2. India Biomarker Testing Services Market
  • 8.4.3. Japan Biomarker Testing Services Market
  • 8.4.4. Australia Biomarker Testing Services Market
  • 8.4.5. South Korea Biomarker Testing Services Market
  • 8.4.6. Rest of Asia Pacific Biomarker Testing Services Market
• 8.5. Latin America Biomarker Testing Services Market Snapshot
  • 8.5.1. Brazil Biomarker Testing Services Market
  • 8.5.2. Mexico Biomarker Testing Services Market
• 8.6. Rest of The World Biomarker Testing Services Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bio Agilytix Labs
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Euro fins Scientific
  • 9.2.3. SGS SA
  • 9.2.4. Charles River Laboratories
  • 9.2.5. Labcorp Drug Development
  • 9.2.6. Thermo Fisher Scientific Inc. (PPD, Inc.)
  • 9.2.7. ICON Plc
  • 9.2.8. IQVIA
  • 9.2.9. Syneos Health
  • 9.2.10. Intertek Group Plc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Biomarker Testing Services Market, report scope
• TABLE 2. Global Biomarker Testing Services Market estimates & forecasts by Region 2019-2029 (USD Million)
• TABLE 3. Global Biomarker Testing Services Market estimates & forecasts by Product 2019-2029 (USD Million)
• TABLE 4. Global Biomarker Testing Services Market estimates & forecasts by End User 2019-2029 (USD Million)
• TABLE 5. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 6. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 7. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 8. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 9. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 10. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 11. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 12. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 13. Global Biomarker Testing Services Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 14. Global Biomarker Testing Services Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 15. U.S. Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 16. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 17. U.S. Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 18. Canada Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 19. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 20. Canada Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 21. UK Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 22. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 23. UK Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 24. Germany Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 25. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 26. Germany Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 27. France Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 28. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 29. France Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 30. Italy Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 31. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 32. Italy Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 33. Spain Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 34. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 35. Spain Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 36. RoE Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 37. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 38. RoE Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 39. China Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 40. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 41. China Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 42. India Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 43. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 44. India Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 45. Japan Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 46. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 47. Japan Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 48. South Korea Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 49. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 50. South Korea Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 51. Australia Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 52. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 53. Australia Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 54. RoAPAC Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 55. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 56. RoAPAC Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 57. Brazil Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 58. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 59. Brazil Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 60. Mexico Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 61. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 62. Mexico Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 63. RoLA Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 64. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 65. RoLA Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 66. Row Biomarker Testing Services Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 67. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 68. Row Biomarker Testing Services Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 69. List of secondary sources, used in the study of global Biomarker Testing Services Market
• TABLE 70. List of primary sources, used in the study of global Biomarker Testing Services Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Biomarker Testing Services Market, research methodology
• FIG 2. Global Biomarker Testing Services Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Biomarker Testing Services Market, key trends 2021
• FIG 5. Global Biomarker Testing Services Market, growth prospects 2022-2029
• FIG 6. Global Biomarker Testing Services Market, porters 5 force model
• FIG 7. Global Biomarker Testing Services Market, pest analysis
• FIG 8. Global Biomarker Testing Services Market, value chain analysis
• FIG 9. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 10. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 11. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 12. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 13. Global Biomarker Testing Services Market by segment, 2019 & 2029 (USD Million)
• FIG 14. Global Biomarker Testing Services Market, regional snapshot 2019 & 2029
• FIG 15. North America Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 16. Europe Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 17. Asia pacific Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 18. Latin America Biomarker Testing Services Market 2019 & 2029 (USD Million)
• FIG 19. Global Biomarker Testing Services Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable